These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 3940273)

  • 21. Inhibitory effect of 5-methoxy-N,N-dimethyltryptamine on the synaptosomal uptake of 5-hydroxytryptamine.
    Berge OG; Chacho D; Hole K
    Eur J Pharmacol; 1983 Jun; 90(2-3):293-6. PubMed ID: 6873188
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Discriminative stimulus properties of quipazine: mediation by serotonin2 binding sites.
    Friedman RL; Barrett RJ; Sanders-Bush E
    J Pharmacol Exp Ther; 1984 Mar; 228(3):628-35. PubMed ID: 6707913
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Serotonin and the mammalian circadian system: I. In vitro phase shifts by serotonergic agonists and antagonists.
    Prosser RA; Dean RR; Edgar DM; Heller HC; Miller JD
    J Biol Rhythms; 1993; 8(1):1-16. PubMed ID: 8490207
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of 1-(m-chlorophenyl)piperazine and 1-(m-trifluoromethylphenyl)piperazine on locomotor activity.
    Lucki I; Ward HR; Frazer A
    J Pharmacol Exp Ther; 1989 Apr; 249(1):155-64. PubMed ID: 2709329
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Induction of purposeless chewing behaviour in rats by 5-HT agonist drugs.
    Stewart BR; Jenner P; Marsden CD
    Eur J Pharmacol; 1989 Mar; 162(1):101-7. PubMed ID: 2524394
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The effects of quipazine on 5-HT metabolism in the rat brain.
    Hamon M; Bourgoin S; Enjalbert A; Bockaert J; Hery F; Ternaux JP; Glowinski J
    Naunyn Schmiedebergs Arch Pharmacol; 1976 Jul; 294(1):99-108. PubMed ID: 1004632
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of serotonin receptor agonists and antagonists on schedule-controlled behavior of squirrel monkeys.
    Brady LS; Barrett JE
    J Pharmacol Exp Ther; 1985 Nov; 235(2):436-41. PubMed ID: 2932546
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Blockade of the behavioral effects of lysergic acid diethylamide, 2,5-dimethoxy-4-methylamphetamine, quipazine and lisuride by 5-hydroxytryptamine antagonists.
    Mokler DJ; Commissaris RL; Warner MR; Rech RH
    J Pharmacol Exp Ther; 1983 Dec; 227(3):557-62. PubMed ID: 6655557
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Behavioural evidence for a functional interaction between central 5-HT2 and 5-HT1A receptors.
    Backus LI; Sharp T; Grahame-Smith DG
    Br J Pharmacol; 1990 Aug; 100(4):793-9. PubMed ID: 2145051
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Drug-induced stimulus control and the concept of breaking point: LSD and quipazine.
    Winter JC
    Psychopharmacology (Berl); 1981; 72(2):217-8. PubMed ID: 6782615
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparison of the patterns of altered cerebral glucose utilisation produced by competitive and non-competitive NMDA receptor antagonists.
    Sharkey J; Ritchie IM; Butcher SP; Kelly JS
    Brain Res; 1996 Sep; 735(1):67-82. PubMed ID: 8905171
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Quipazine-induced stimulus control in the rat.
    Winter JC
    Psychopharmacology (Berl); 1979 Feb; 60(3):265-9. PubMed ID: 108704
    [No Abstract]   [Full Text] [Related]  

  • 33. Prevention of the serotonin syndrome in rats by repeated administration of monoamine oxidase inhibitors but not tricyclic antidepressants.
    Lucki I; Frazer A
    Psychopharmacology (Berl); 1982; 77(3):205-11. PubMed ID: 6812141
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of methiothepin and lysergic acid diethylamide on serotonin release in vitro and serotonin synthesis in vivo: possible relation to serotonin autoreceptor function.
    Pettibone DJ; Pflueger AB
    J Neurochem; 1984 Jul; 43(1):83-90. PubMed ID: 6726257
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inhibition of prolactin release by stimulation of presynaptic serotonin autoreceptors.
    Clemens JA; Roush ME
    Life Sci; 1982 Dec; 31(23):2641-6. PubMed ID: 7154858
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Time- and dose-dependent effects of the serotonergic agent quipazine on regional cerebral metabolism in rats.
    Freo U; Ricchieri GL; Holloway HW; Soncrant TT
    Brain Res; 1993 Jan; 600(2):249-56. PubMed ID: 8435750
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of NMDA antagonists, MK-801 and CPP, upon local cerebral glucose use.
    Kurumaji A; Nehls DG; Park CK; McCulloch J
    Brain Res; 1989 Sep; 496(1-2):268-84. PubMed ID: 2553203
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Medullary serotonergic neurons are insensitive to 5-MeoDMT and LSD.
    Heym J; Steinfels GF; Jacobs BL
    Eur J Pharmacol; 1982 Jul; 81(4):677-80. PubMed ID: 7117390
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of MK-801 upon local cerebral glucose utilisation in conscious rats and in rats anaesthetised with halothane.
    Kurumaji A; McCulloch J
    J Cereb Blood Flow Metab; 1989 Dec; 9(6):786-94. PubMed ID: 2684992
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Development of tolerance to repeated administration of 5-methoxy-N,N-dimethyltryptamine in rats.
    Trulson ME; Keltch GF
    Eur J Pharmacol; 1985 Jan; 108(1):33-7. PubMed ID: 3979433
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.